 | • レポートコード：D005-00899 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、127ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、皮膚ガンの世界市場を広く調査・分析し、今後の市場展望をまとめております。皮膚ガンの種類別市場規模（細胞がん、扁平上皮がん、メラノーマ）、用途別市場規模（病院・診療所、診断センター、がん研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Roche、LEO Pharma、Elekta、Novartis、Cellceutix、Sun Pharma、Mylan、Cannabis Science、Varian Medical Systems、Moberg Pharma、Bausch Health、Eli Lilly、Merck、Aqua Pharmaceuticals、Bristol Myers Squibb、Boehringer Ingelheim ・地域別グローバル市場分析 2015年-2020年 ・皮膚ガンの北米市場（アメリカ、カナダ、メキシコ） ・皮膚ガンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・皮膚ガンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・皮膚ガンの南米市場（ブラジル、アルゼンチン） ・皮膚ガンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：細胞がん、扁平上皮がん、メラノーマ ・用途別分析：病院・診療所、診断センター、がん研究所 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Skin Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.7% in the forecast period of 2020 to 2025 and will expected to reach USD 608.3 million by 2025, from USD 505.3 million in 2019.
The Skin Cancer market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Skin Cancer market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Skin Cancer market has been segmented into:
Cell carcinoma
Squamous-cell carcinoma
Melanoma
By Application, Skin Cancer has been segmented into:
Hospital and clinics
Diagnostic centers
Cancer research institute
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Skin Cancer market presented in the report. This section sheds light on the sales growth of different regional and country-level Skin Cancer markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Skin Cancer market.
The report offers in-depth assessment of the growth and other aspects of the Skin Cancer market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Skin Cancer Market Share Analysis
Skin Cancer competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Skin Cancer sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Skin Cancer sales, revenue and market share for each player covered in this report.
The major players covered in Skin Cancer are:
Roche
LEO Pharma
Elekta
Novartis
Cellceutix
Sun Pharma
Mylan
Cannabis Science
Varian Medical Systems
Moberg Pharma
Bausch Health
Eli Lilly
Merck
Aqua Pharmaceuticals
Bristol Myers Squibb
Boehringer Ingelheim
Table of Contents
1 Skin Cancer Market Overview
1.1 Product Overview and Scope of Skin Cancer
1.2 Classification of Skin Cancer by Type
1.2.1 Global Skin Cancer Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Skin Cancer Revenue Market Share by Type in 2019
1.2.3 Cell carcinoma
1.2.4 Squamous-cell carcinoma
1.2.5 Melanoma
1.3 Global Skin Cancer Market by Application
1.3.1 Overview: Global Skin Cancer Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital and clinics
1.3.3 Diagnostic centers
1.3.4 Cancer research institute
1.4 Global Skin Cancer Market by Regions
1.4.1 Global Skin Cancer Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Skin Cancer (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Skin Cancer Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Skin Cancer Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Skin Cancer Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Skin Cancer Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Skin Cancer Status and Prospect (2015-2025)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Roche SWOT Analysis
2.1.4 Roche Product and Services
2.1.5 Roche Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.2 LEO Pharma
2.2.1 LEO Pharma Details
2.2.2 LEO Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 LEO Pharma SWOT Analysis
2.2.4 LEO Pharma Product and Services
2.2.5 LEO Pharma Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.3 Elekta
2.3.1 Elekta Details
2.3.2 Elekta Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Elekta SWOT Analysis
2.3.4 Elekta Product and Services
2.3.5 Elekta Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.5 Cellceutix
2.5.1 Cellceutix Details
2.5.2 Cellceutix Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Cellceutix SWOT Analysis
2.5.4 Cellceutix Product and Services
2.5.5 Cellceutix Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sun Pharma
2.6.1 Sun Pharma Details
2.6.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sun Pharma SWOT Analysis
2.6.4 Sun Pharma Product and Services
2.6.5 Sun Pharma Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Mylan SWOT Analysis
2.7.4 Mylan Product and Services
2.7.5 Mylan Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.8 Cannabis Science
2.8.1 Cannabis Science Details
2.8.2 Cannabis Science Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Cannabis Science SWOT Analysis
2.8.4 Cannabis Science Product and Services
2.8.5 Cannabis Science Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.9 Varian Medical Systems
2.9.1 Varian Medical Systems Details
2.9.2 Varian Medical Systems Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Varian Medical Systems SWOT Analysis
2.9.4 Varian Medical Systems Product and Services
2.9.5 Varian Medical Systems Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.10 Moberg Pharma
2.10.1 Moberg Pharma Details
2.10.2 Moberg Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Moberg Pharma SWOT Analysis
2.10.4 Moberg Pharma Product and Services
2.10.5 Moberg Pharma Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.11 Bausch Health
2.11.1 Bausch Health Details
2.11.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Bausch Health SWOT Analysis
2.11.4 Bausch Health Product and Services
2.11.5 Bausch Health Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.12 Eli Lilly
2.12.1 Eli Lilly Details
2.12.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Eli Lilly SWOT Analysis
2.12.4 Eli Lilly Product and Services
2.12.5 Eli Lilly Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.13 Merck
2.13.1 Merck Details
2.13.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Merck SWOT Analysis
2.13.4 Merck Product and Services
2.13.5 Merck Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.14 Aqua Pharmaceuticals
2.14.1 Aqua Pharmaceuticals Details
2.14.2 Aqua Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Aqua Pharmaceuticals SWOT Analysis
2.14.4 Aqua Pharmaceuticals Product and Services
2.14.5 Aqua Pharmaceuticals Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.15 Bristol Myers Squibb
2.15.1 Bristol Myers Squibb Details
2.15.2 Bristol Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Bristol Myers Squibb SWOT Analysis
2.15.4 Bristol Myers Squibb Product and Services
2.15.5 Bristol Myers Squibb Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
2.16 Boehringer Ingelheim
2.16.1 Boehringer Ingelheim Details
2.16.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Boehringer Ingelheim SWOT Analysis
2.16.4 Boehringer Ingelheim Product and Services
2.16.5 Boehringer Ingelheim Skin Cancer Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Skin Cancer Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Skin Cancer Players Market Share
3.2.2 Top 10 Skin Cancer Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Skin Cancer Revenue and Market Share by Regions
4.2 North America Skin Cancer Revenue and Growth Rate (2015-2020)
4.3 Europe Skin Cancer Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Skin Cancer Revenue and Growth Rate (2015-2020)
4.5 South America Skin Cancer Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Skin Cancer Revenue and Growth Rate (2015-2020)
5 North America Skin Cancer Revenue by Countries
5.1 North America Skin Cancer Revenue by Countries (2015-2020)
5.2 USA Skin Cancer Revenue and Growth Rate (2015-2020)
5.3 Canada Skin Cancer Revenue and Growth Rate (2015-2020)
5.4 Mexico Skin Cancer Revenue and Growth Rate (2015-2020)
6 Europe Skin Cancer Revenue by Countries
6.1 Europe Skin Cancer Revenue by Countries (2015-2020)
6.2 Germany Skin Cancer Revenue and Growth Rate (2015-2020)
6.3 UK Skin Cancer Revenue and Growth Rate (2015-2020)
6.4 France Skin Cancer Revenue and Growth Rate (2015-2020)
6.5 Russia Skin Cancer Revenue and Growth Rate (2015-2020)
6.6 Italy Skin Cancer Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Skin Cancer Revenue by Countries
7.1 Asia-Pacific Skin Cancer Revenue by Countries (2015-2020)
7.2 China Skin Cancer Revenue and Growth Rate (2015-2020)
7.3 Japan Skin Cancer Revenue and Growth Rate (2015-2020)
7.4 Korea Skin Cancer Revenue and Growth Rate (2015-2020)
7.5 India Skin Cancer Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Skin Cancer Revenue and Growth Rate (2015-2020)
8 South America Skin Cancer Revenue by Countries
8.1 South America Skin Cancer Revenue by Countries (2015-2020)
8.2 Brazil Skin Cancer Revenue and Growth Rate (2015-2020)
8.3 Argentina Skin Cancer Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Skin Cancer by Countries
9.1 Middle East & Africa Skin Cancer Revenue by Countries (2015-2020)
9.2 Saudi Arabia Skin Cancer Revenue and Growth Rate (2015-2020)
9.3 UAE Skin Cancer Revenue and Growth Rate (2015-2020)
9.4 Egypt Skin Cancer Revenue and Growth Rate (2015-2020)
9.5 South Africa Skin Cancer Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Skin Cancer Revenue and Market Share by Type (2015-2020)
10.2 Global Skin Cancer Market Forecast by Type (2019-2024)
10.3 Cell carcinoma Revenue Growth Rate (2015-2025)
10.4 Squamous-cell carcinoma Revenue Growth Rate (2015-2025)
10.5 Melanoma Revenue Growth Rate (2015-2025)
11 Global Skin Cancer Market Segment by Application
11.1 Global Skin Cancer Revenue Market Share by Application (2015-2020)
11.2 Skin Cancer Market Forecast by Application (2019-2024)
11.3 Hospital and clinics Revenue Growth (2015-2020)
11.4 Diagnostic centers Revenue Growth (2015-2020)
11.5 Cancer research institute Revenue Growth (2015-2020)
12 Global Skin Cancer Market Size Forecast (2021-2025)
12.1 Global Skin Cancer Market Size Forecast (2021-2025)
12.2 Global Skin Cancer Market Forecast by Regions (2021-2025)
12.3 North America Skin Cancer Revenue Market Forecast (2021-2025)
12.4 Europe Skin Cancer Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Skin Cancer Revenue Market Forecast (2021-2025)
12.6 South America Skin Cancer Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Skin Cancer Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Skin Cancer Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Skin Cancer by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Skin Cancer Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Skin Cancer Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Roche Corporate Information, Location and Competitors
Table 6. Roche Skin Cancer Major Business
Table 7. Roche Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 8. Roche SWOT Analysis
Table 9. Roche Skin Cancer Product and Solutions
Table 10. Roche Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. LEO Pharma Corporate Information, Location and Competitors
Table 12. LEO Pharma Skin Cancer Major Business
Table 13. LEO Pharma Skin Cancer Total Revenue (USD Million) (2018-2019)
Table 14. LEO Pharma SWOT Analysis
Table 15. LEO Pharma Skin Cancer Product and Solutions
Table 16. LEO Pharma Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Elekta Corporate Information, Location and Competitors
Table 18. Elekta Skin Cancer Major Business
Table 19. Elekta Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 20. Elekta SWOT Analysis
Table 21. Elekta Skin Cancer Product and Solutions
Table 22. Elekta Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis Skin Cancer Major Business
Table 25. Novartis Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis Skin Cancer Product and Solutions
Table 28. Novartis Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Cellceutix Corporate Information, Location and Competitors
Table 30. Cellceutix Skin Cancer Major Business
Table 31. Cellceutix Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 32. Cellceutix SWOT Analysis
Table 33. Cellceutix Skin Cancer Product and Solutions
Table 34. Cellceutix Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Sun Pharma Corporate Information, Location and Competitors
Table 36. Sun Pharma Skin Cancer Major Business
Table 37. Sun Pharma Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 38. Sun Pharma SWOT Analysis
Table 39. Sun Pharma Skin Cancer Product and Solutions
Table 40. Sun Pharma Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Mylan Corporate Information, Location and Competitors
Table 42. Mylan Skin Cancer Major Business
Table 43. Mylan Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 44. Mylan SWOT Analysis
Table 45. Mylan Skin Cancer Product and Solutions
Table 46. Mylan Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Cannabis Science Corporate Information, Location and Competitors
Table 48. Cannabis Science Skin Cancer Major Business
Table 49. Cannabis Science Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 50. Cannabis Science SWOT Analysis
Table 51. Cannabis Science Skin Cancer Product and Solutions
Table 52. Cannabis Science Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Varian Medical Systems Corporate Information, Location and Competitors
Table 54. Varian Medical Systems Skin Cancer Major Business
Table 55. Varian Medical Systems Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 56. Varian Medical Systems SWOT Analysis
Table 57. Varian Medical Systems Skin Cancer Product and Solutions
Table 58. Varian Medical Systems Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Moberg Pharma Corporate Information, Location and Competitors
Table 60. Moberg Pharma Skin Cancer Major Business
Table 61. Moberg Pharma Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 62. Moberg Pharma SWOT Analysis
Table 63. Moberg Pharma Skin Cancer Product and Solutions
Table 64. Moberg Pharma Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Bausch Health Corporate Information, Location and Competitors
Table 66. Bausch Health Skin Cancer Major Business
Table 67. Bausch Health Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 68. Bausch Health SWOT Analysis
Table 69. Bausch Health Skin Cancer Product and Solutions
Table 70. Bausch Health Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Eli Lilly Corporate Information, Location and Competitors
Table 72. Eli Lilly Skin Cancer Major Business
Table 73. Eli Lilly Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 74. Eli Lilly SWOT Analysis
Table 75. Eli Lilly Skin Cancer Product and Solutions
Table 76. Eli Lilly Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Merck Corporate Information, Location and Competitors
Table 78. Merck Skin Cancer Major Business
Table 79. Merck Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 80. Merck SWOT Analysis
Table 81. Merck Skin Cancer Product and Solutions
Table 82. Merck Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Aqua Pharmaceuticals Corporate Information, Location and Competitors
Table 84. Aqua Pharmaceuticals Skin Cancer Major Business
Table 85. Aqua Pharmaceuticals Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 86. Aqua Pharmaceuticals SWOT Analysis
Table 87. Aqua Pharmaceuticals Skin Cancer Product and Solutions
Table 88. Aqua Pharmaceuticals Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 89. Bristol Myers Squibb Corporate Information, Location and Competitors
Table 90. Bristol Myers Squibb Skin Cancer Major Business
Table 91. Bristol Myers Squibb Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 92. Bristol Myers Squibb SWOT Analysis
Table 93. Bristol Myers Squibb Skin Cancer Product and Solutions
Table 94. Bristol Myers Squibb Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 95. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 96. Boehringer Ingelheim Skin Cancer Major Business
Table 97. Boehringer Ingelheim Skin Cancer Total Revenue (USD Million) (2017-2018)
Table 98. Boehringer Ingelheim SWOT Analysis
Table 99. Boehringer Ingelheim Skin Cancer Product and Solutions
Table 100. Boehringer Ingelheim Skin Cancer Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 101. Global Skin Cancer Revenue (Million USD) by Players (2015-2020)
Table 102. Global Skin Cancer Revenue Share by Players (2015-2020)
Table 103. Global Skin Cancer Revenue (Million USD) by Regions (2015-2020)
Table 104. Global Skin Cancer Revenue Market Share by Regions (2015-2020)
Table 105. North America Skin Cancer Revenue by Countries (2015-2020)
Table 106. North America Skin Cancer Revenue Market Share by Countries (2015-2020)
Table 107. Europe Skin Cancer Revenue (Million USD) by Countries (2015-2020)
Table 108. Asia-Pacific Skin Cancer Revenue (Million USD) by Countries (2015-2020)
Table 109. South America Skin Cancer Revenue by Countries (2015-2020)
Table 110. South America Skin Cancer Revenue Market Share by Countries (2015-2020)
Table 111. Middle East and Africa Skin Cancer Revenue (Million USD) by Countries (2015-2020)
Table 112. Middle East and Africa Skin Cancer Revenue Market Share by Countries (2015-2020)
Table 113. Global Skin Cancer Revenue (Million USD) by Type (2015-2020)
Table 114. Global Skin Cancer Revenue Share by Type (2015-2020)
Table 115. Global Skin Cancer Revenue Forecast by Type (2021-2025)
Table 116. Global Skin Cancer Revenue by Application (2015-2020)
Table 117. Global Skin Cancer Revenue Share by Application (2015-2020)
Table 118. Global Skin Cancer Revenue Forecast by Application (2021-2025)
Table 119. Global Skin Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Skin Cancer Picture
Figure 2. Global Skin Cancer Revenue Market Share by Type in 2019
Figure 3. Cell carcinoma Picture
Figure 4. Squamous-cell carcinoma Picture
Figure 5. Melanoma Picture
Figure 6. Skin Cancer Revenue Market Share by Application in 2019
Figure 7. Hospital and clinics Picture
Figure 8. Diagnostic centers Picture
Figure 9. Cancer research institute Picture
Figure 10. Global Skin Cancer Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America Skin Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe Skin Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific Skin Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America Skin Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa Skin Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Skin Cancer Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Skin Cancer Revenue Share by Players in 2019
Figure 18. Global Top 5 Players Skin Cancer Revenue Market Share in 2019
Figure 19. Global Top 10 Players Skin Cancer Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global Skin Cancer Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global Skin Cancer Revenue Market Share by Regions (2015-2020)
Figure 23. Global Skin Cancer Revenue Market Share by Regions in 2018
Figure 24. North America Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 25. Europe Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 27. South America Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 29. North America Skin Cancer Revenue Market Share by Countries (2015-2020)
Figure 30. North America Skin Cancer Revenue Market Share by Countries in 2019
Figure 31. USA Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 32. Canada Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 33. Mexico Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 34. Europe Skin Cancer Revenue Market Share by Countries (2015-2020)
Figure 35. Europe Skin Cancer Revenue Market Share by Countries in 2019
Figure 36. Germany Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 37. UK Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 38. France Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 39. Russia Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 40. Italy Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Skin Cancer Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific Skin Cancer Revenue Market Share by Countries in 2019
Figure 43. China Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 44. Japan Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 45. Korea Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 46. India Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 48. South America Skin Cancer Revenue Market Share by Countries (2015-2020)
Figure 49. South America Skin Cancer Revenue Market Share by Countries in 2019
Figure 50. Brazil Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 51. Argentina Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa Skin Cancer Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa Skin Cancer Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 55. UAE Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 56. Egypt Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 57. South Africa Skin Cancer Revenue and Growth Rate (2015-2020)
Figure 58. Global Skin Cancer Revenue Share by Type (2015-2020)
Figure 59. Global Skin Cancer Revenue Share by Type in 2019
Figure 60. Global Skin Cancer Market Share Forecast by Type (2021-2025)
Figure 61. Global Cell carcinoma Revenue Growth Rate (2015-2020)
Figure 62. Global Squamous-cell carcinoma Revenue Growth Rate (2015-2020)
Figure 63. Global Melanoma Revenue Growth Rate (2015-2020)
Figure 64. Global Skin Cancer Revenue Share by Application (2015-2020)
Figure 65. Global Skin Cancer Revenue Share by Application in 2019
Figure 66. Global Skin Cancer Market Share Forecast by Application (2021-2025)
Figure 67. Global Hospital and clinics Revenue Growth Rate (2015-2020)
Figure 68. Global Diagnostic centers Revenue Growth Rate (2015-2020)
Figure 69. Global Cancer research institute Revenue Growth Rate (2015-2020)
Figure 70. Global Skin Cancer Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global Skin Cancer Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global Skin Cancer Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America Skin Cancer Revenue Market Forecast (2021-2025)
Figure 74. Europe Skin Cancer Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific Skin Cancer Revenue Market Forecast (2021-2025)
Figure 76. South America Skin Cancer Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa Skin Cancer Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
皮膚がん診断の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Skin Cancer Diagnostics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Skin Cancer Diagnosti…- 皮膚がん診断・治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Skin Cancer Diagnosis and Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Skin C…
- 移行上皮がん治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Transitional Cell Cancer Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Transit…
- 腎臓がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Kidney Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Kidney Cancer market report pro…
- 黒色腫がんの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Melanoma Cancer market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Melanoma Cancer market report…